Literature DB >> 21680995

Clinical interpretation of indices of quality of glycemic control and glycemic variability.

David Rodbard1.   

Abstract

The practicing physician is faced with the task of interpreting>2 dozen indices of quality of glycemic control and glycemic variability. It would be desirable to have reference data from relevant patient populations (eg, patients with the same type of diabetes, duration of diabetes, therapeutic regimen, or glycated hemoglobin [HbA1c] levels). The physician can then select the appropriate reference set for interpretation of results for each patient. Institutions and clinics may wish to develop their own reference data. Results can be interpreted as excellent, good, fair, or poor, corresponding with quartiles of their distributions. Each index of glycemic control and variability can be given a numerical score in terms of its percentile within the selected reference population. One can then compute the mean and standard deviation of the percentile scores to obtain an integrated measure of the quality of glycemic control or variability. We calculated quartiles for measures of quality of glycemic control and variability. One can use the percent coefficient of variation (%CV) with criteria that apply irrespective of the HbA1c level as a general rule for interpretation of glycemic variability. For example, a %CV<33.5% can be regarded as excellent, a %CV between 33.5% to 36.8% as good, a %CV between 36.8% to 40.6% as fair, and a %CV>40.6% as poor. A graphical display can be used to make more accurate assessments for narrow HbA1c ranges, as the percentiles of the %CV can change systematically with HbA1c level or with mean glucose level.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680995     DOI: 10.3810/pgm.2011.07.2310

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  39 in total

Review 1.  The challenges of measuring glycemic variability.

Authors:  David Rodbard
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

2.  Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index.

Authors:  Lalantha Leelarathna; Hood Thabit; Malgorzata E Wilinska; Lia Bally; Julia K Mader; Thomas R Pieber; Carsten Benesch; Sabine Arnolds; Terri Johnson; Lutz Heinemann; Norbert Hermanns; Mark L Evans; Roman Hovorka
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

3.  Modeling Inpatient Glucose Management Programs on Hospital Infection Control Programs: An Infrastructural Model of Excellence.

Authors:  Nestoras Mathioudakis; Peter J Pronovost; Sara E Cosgrove; Daniel Hager; Sherita Hill Golden
Journal:  Jt Comm J Qual Patient Saf       Date:  2015-07

Review 4.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 5.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

Review 6.  Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.

Authors:  Guillermo E Umpierrez; Boris P Kovatchev
Journal:  Am J Med Sci       Date:  2018-10-02       Impact factor: 2.378

7.  Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.

Authors:  Thomas A Peyser; Andrew K Balo; Bruce A Buckingham; Irl B Hirsch; Arturo Garcia
Journal:  Diabetes Technol Ther       Date:  2017-12-11       Impact factor: 6.118

Review 8.  Continuous Glucose Monitoring: A Review of Successes, Challenges, and Opportunities.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2016-02       Impact factor: 6.118

9.  A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control.

Authors:  Michelle Nguyen; Julia Han; Elias K Spanakis; Boris P Kovatchev; David C Klonoff
Journal:  Diabetes Technol Ther       Date:  2020-03-04       Impact factor: 6.118

Review 10.  Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.

Authors:  Susan S Braithwaite
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.